Micro<scp>RNA</scp>‐23b promotes tolerogenic properties of dendritic cells <i>in vitro</i> through inhibiting <scp>N</scp>otch1/<scp>NF</scp>‐κ<scp>B</scp> signalling pathways

Abstract

Our findings provide evidence that miR-23b is capable of inducing tolerogenic DC activity and Treg responses in vitro through the inhibition of the Notch1 and NF-κB signalling pathways; thus, miR-23b might represent a therapeutic target for the management of allergic diseases.